Federal contract award
36C24526N0288
MAVACAMTEN (CAMZYOS) 5 MG AND POMALIDOMIDE (POMALYST) 2 MG
Award details
Obligations, current value and potential value describe different measures; they are never added together.
| Field | Reported value |
|---|---|
| Agency | Department of Veterans Affairs |
| Office | 245-NETWORK CONTRACT OFFICE 5 (36C245) |
| NAICS | 325412 — Pharmaceutical Preparation Manufacturing |
| PSC | 6505 — Drugs and Biologicals |
| Parent award / vehicle | 36E79726A0010 |
| Set-aside | Not reported |
| Pricing type | FIRM FIXED PRICE |
| Obligations | $232.8K |
| Current contract value | $232.8K |
| Potential contract value / ceiling | $232.8K |
| Start date | Feb 17, 2026 |
| Current end date | Sep 30, 2026 |
| Potential end date | Sep 30, 2026 |
| Latest award activity | Jul 17, 2026 |
| Source loaded | Sep 26, 2026 |
Funding and modification history
Showing the latest 2 of 2 loaded transactions. Negative values are deobligations.
| Date | Modification | Obligation change | Description |
|---|---|---|---|
| Jul 17, 2026 | P00001 | $49.3K | MAVACAMTEN (CAMZYOS) 5 MG AND POMALIDOMIDE (POMALYST) 2 MG |
| Feb 17, 2026 | 0 | $183.5K | MAVACAMTEN (CAMZYOS) 5 MG AND POMALIDOMIDE (POMALYST) 2 MG |
Research next steps
- Confirm the ordering vehicle and your eligibility or a qualified teaming route.
- Review the award scope and buyer evidence before making a bid/no-bid decision.